US 7803614
Melanoma antigens and their use in diagnostic and therapeutic methods
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 7803614 (Melanoma antigens and their use in diagnostic and therapeutic methods) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/57, A61K38/00